| Protocol ID | NCT07216404 |
| Registration Date | 2025-10-14 |
| Status | recruiting |
| Sponsor | Alan Davis |
| Country | United States |
| Industry | not industry |
| Blinding | unblinded |
| Center Type | singel-center RCT |
| Scope | national RCT |
| First Patient In | 2026-04-15 |
| Last Patient Out | 2027-10-31 |
| Publication | n |
| Gender % | ALL |
| Mean Age | 18 Years - |
NCT07216404
Exploring the Safety, Acceptability, and Efficacy of Psilocybin Among Non-Small Cell Lung Cancer Patients With Major Depressive Disorder: A Proof-of-Concept Trial (DREAM LUNG STUDY)
| Field |
CLAUDE
claude-sonnet-4-20250514 6681ms / 12865 tok |
OPENAI
gpt-4o 6397ms / 11098 tok |
GLM
glm-5.1 8621ms / 11277 tok |
Review |
|---|---|---|---|---|
| rct_type | N/A | N/A | N/A | OK |
| cancer_status | Cancer | Cancer | Cancer | OK |
| non_cancer_spec | N/A | N/A | N/A | OK |
| setting_patient | outpatient | outpatient | outpatient | OK |
| setting_place | other | other | other | OK |
| feasibility | feasibility RCT | feasibility RCT | feasibility RCT | OK |
| intervention_pharmacologic | yes | yes | yes | OK |
| intervention_chemo_immuno_radio | no | no | no | OK |
| intervention_complementary | no | no | no | OK |
| intervention_device | no | no | no | OK |
| intervention_psychological | yes | yes | yes | OK |
| intervention_complex | yes | yes | yes | OK |
| intervention_acp | no | no | no | OK |
| intervention_music | no | no | no | OK |
| intervention_screening | no | no | no | OK |
| intervention_palliative |
no
yes → no
shaky reasoning✓ Unanimous
Initial: yes
Requery: no — This study tests psilocybin as a pharmacologic intervention for depression in lung cancer patients, not palliative care consultation or service delivery as the intervention.
|
no
no → no
shaky reasoning✓ Unanimous
Initial: no
Requery: no — The trial tests the safety and efficacy of psilocybin-assisted therapy for depression in lung cancer patients, not palliative care as an intervention.
|
no
yes → no
shaky reasoning✓ Unanimous
Initial: yes
Requery: no — The intervention is a pharmacologic drug trial (psilocybin) paired with psychotherapy to treat depression in cancer patients, which is a specific therapy tested within a cancer care setting rather than testing palliative care itself as the intervention.
|
OK |
| intervention_education | no | no | no | OK |
| intervention_digital | no | no | no | OK |
| intervention_other | no | no | no | OK |
| outcome_symptom | yes | yes | yes | OK |
| outcome_qol | yes | yes | yes | OK |
| outcome_dignity | yes | yes | yes | OK |
| outcome_cost | no | no | no | OK |
| outcome_other | yes | yes | yes | OK |
| pharmacologic_sub | controlled substances | controlled substances | controlled substances | OK |